Quadrature Capital’s MiMedx Group MDXG Stock Holding History

Quadrature Capital’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-30,316	Closed	-$120K	–	1871
2026 Q1	$120K	Buy	+30,316	New	+$153K	﹤0.01%	1200

Other funds holding MDXG

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Quadrature Capital's MDXG Position: Q2 2026 in Review

Quadrature Capital sold out of MiMedx Group (MDXG) in Q2 2026, closing a stake of 30,316 shares — an estimated $120K sold.

Quadrature Capital first reported a position in MDXG in Q1 2026 and held it in 1 quarter. The position peaked at $120K in Q1 2026. 227 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

Quadrature Capital reported no remaining MiMedx Group position as of Q2 2026 after selling out during the quarter.
Quadrature Capital sold 30,316 MiMedx Group shares in Q2 2026, an estimated $120K.
Quadrature Capital first reported a position in MiMedx Group in Q1 2026 and held it in 1 quarter.
Quadrature Capital's MiMedx Group position peaked at $120K in Q1 2026.
227 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.